je.st
news
Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness
2013-07-29 23:01:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Historic Milestone Reflects Successful Collaboration Among MECTIZAN Donation Program and Partners WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, applauds the government of Colombia whose work with the MECTIZAN Donation Program and The Carter Center-sponsored Onchocerciasis Elimination Program for the Americas led to todays Pan American Health Organization, the World Health Organizations Regional Office for the Americas (PAHO/WHO), verification of Colombia as the first country in the world to eliminate the transmission of river blindness (onchocerciasis), using MECTIZAN (iv Language: English Contact: MerckLainie Keller, 908-423-4187 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: of
river
colombia
verification
Category:Biotechnology and Pharmaceuticals